Evaluation of glycopyrrolate in the treatment of chronic drooling

luation of glycopyrrolate in the treatment of chronic drooling Review (3281) Total Article Views Authors: Reddihough DS, Reid SM, Plover C Published Date May 2011 Volume 2011:1 Pages 3 - 7 DOI: http://dx.doi.org/10.2147/DNND.S16084 DS Reddihough1,2,3, SM Reid2,3, C Plover1 1Royal Children's Hospital, Melbourne, VIC, Australia; 2Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia; 3University of Melbourne, Melbourne, VIC, Australia Abstract: Drooling is a major problem for children and adults with cerebral palsy and other neurological conditions. Medication is a major treatment option for these individuals. The focus of this review is to review glycopyrrolate, one of the frequently used medications for poor saliva control. Glycopyrrolate is a quaternary ammonium compound structurally related to atropine. The pharmacology, mode of action and pharmocokinetics are discussed, efficacy studies are reviewed, and safety and tolerability are described. Mention is made of the limited amount of information that is available on patient satisfaction and quality of life. Glycopyrrolate has an important place in the treatment of chronic drooling and possible uses for this medication are described. Further research would be helpful comparing glycopyrrolate with other anticholinergic medication and alternative treatments for drooling including botulinum toxins and surgical procedures.